We are delighted to further strengthen our already great relationship with Rigshospitalet in Copenhagen by having signed a supply agreement for Astatine-211.
The supplied At-211 will be used to further develop and optimise our C100 module for automated At-211 purification and radiolabelling, as well as in drug development projects with customers.
Are you interested in the “Goldilocks of alpha-emitters”; At-211? Read more about how Atley Solutions can support your drug development, and feel free to contact us.